Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.

Abstract

BACKGROUND Prostate cancer is the most common cancer in American men and the second leading cause of cancer death. All clinical observations correlate poorly differentiated high-grade prostate cancer with disease-specific mortality. The HER2 cell membrane tyrosine kinase, a member of the epidermal growth factor receptor family that is the transcription… (More)

Topics

Cite this paper

@article{Lyne1997TissueEO, title={Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.}, author={John Christopher Lyne and Mona F. Melhem and Gene G. Finley and D X Wen and Ni Liu and Daming Deng and Raoul R. Salup}, journal={The cancer journal from Scientific American}, year={1997}, volume={3 1}, pages={21-30} }